Comparison of effects of propofol and isosorbide dinitrateduring rewarming on cardiopulmonary bypass
Abstract
Objectives: Comparison of effects of propofol and isosorbide dinitrate during rewarming on cardiopulmonary bypass in patients undergoing coronary artery bypasses grafting.
Methods: It was randomized prospective clinical trial. One hundred and twenty patient (120) undergoing CABG surgery were included in this study. Group-I (Study group, n=60): in which only propofol infusion used during rewarming and Group-II (control Group, n=60) in which isosorbide dinitrate and propofol infusion combination was used during rewarming. The data was entered and analyzed through SPSS Version 19. Independent sample T-test and chi-square test were used for data analysis. P value of ≤ 0.05 was taken as significant.
Results: Mean arterial pressures during rewarming were 63.41±3.61 mmHg in propofol group versus 60.80±4.86 mmHg in control group (p-value 0.001). Core temperature on weaning from cardiopulmonary bypass was 37.11±0.49 oC in propofol group and 37.00±0.18 oC in control group. After drop in core temperature was little more in propofol group (1.02±0.36 oC) versus 0.96±0.37 oC in control group but this difference was not statistically significant (p-value 0.41). Mean Ventilation time after surgery in propofol group was 4.65±0.65 hours versus 5.03±0.81 hours in control group (p-value 0.006).
Conclusion: Propofol alone is capable of fulfilling the requirements of adequate rewarming during Cardiopulmonary bypass and can produce more hemodynamic stability and early post-operative recovery.
doi: http://dx.doi.org/10.12669/pjms.324.10190
How to cite this:Furqan A, Ahmad S, Ali L, Akhtar R, Raza Baig MA, Altaf R. Comparison of effects of propofol and isosorbide dinitrate during rewarming on cardiopulmonary bypass. Pak J Med Sci. 2016;32(4):806-810. Â Â doi: http://dx.doi.org/10.12669/pjms.324.10190
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Refbacks
- There are currently no refbacks.